FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)
Go back to FDA Approves Pfizer's Supplemental New Drug Application for CIBINQO® (abrocitinib)| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 +0.28 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $28.43 | P/E | 17.01 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 37,094,598 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.07 +0.28 (1.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.79 | 52 Week High | $37.39 | |||
| Open | $27.77 | 52 Week Low | $28.25 | |||
| Day High | $28.43 | P/E | 17.01 | |||
| Day Low | $27.66 | EPS | $1.65 | |||
| Volume | 37,094,598 | |||||
